SEC Form 4 · accession 0001209191-16-123503
XBiotech Inc. · XBIT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
W Thorpe McKenzie
Director · 10% Owner
Period of report
May 26, 2016
Accepted (ET)
May 26, 2016 · 3:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001626878
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | May 26, 2016 | P | 5,000 | $13.764 | A | 5,000 | I | By child |
| Common Stock | May 26, 2016 | P | 5,000 | $13.998 | A | 5,000 | I | By child |
| Common Stock | May 26, 2016 | P | 5,000 | $14.012 | A | 5,000 | I | By child |
| Common Stock | May 26, 2016 | P | 5,000 | $14.049 | A | 5,000 | I | By child |
| Common Stock | holding | — | — | — | 5,750 | I | By Trust | |
| Common Stock | holding | — | — | — | 5,750 | I | By Trust | |
| Common Stock | holding | — | — | — | 3,898,600 | D | ||
| Common Stock | holding | — | — | — | 100,000 | I | By Foundation | |
| Common Stock | holding | — | — | — | 100,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.